Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Pharmaceutical Preparations”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources
PubMed1993

Binding of cytokines to pharmaceutically prepared human immunoglobulin.

Pharmaceutically prepared IgG, pooled from sera of over 2,000 normal individuals, contained both monomeric and dimeric IgG. Each type of IgG bound 125I-labeled interleukin (IL)-1 alpha, IL-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha. Increased binding to IgG was observed if 125I-IL-1 beta was denatured by heating to 39 degrees C. However, the binding of both nondenatured and denatured 125I-IL-1 beta was not inhibited by unlabeled IL-1 beta. In contrast, binding of 125I-IL-1 alpha, 125I-IL-6, and 125I-TNF alpha was inhibited by the corresponding unlabeled cytokine. Papain-digestion of IgG abolished binding of 125I-TNF alpha but failed to influence the displaceable binding of 125I-IL-1 alpha and 125I-IL-6. 125I-TNF alpha was a mixture of trimeric and monomeric forms, the latter being the predominant form at lower concentrations. The apparent saturability of 125I-TNF alpha was explained by a higher nonspecific binding of monomeric than of trimeric 125I-TNF alpha to IgG. The amounts of cytokine antibodies in IgG preparations would contribute approximately 2 micrograms anti-IL-1 alpha IgG and 1 microgram anti-IL-6 IgG per kg body wt during high dose immune globulin therapy. In conclusion, pharmaceutical preparations of human IgG contain specific and neutralizing, high affinity antibodies against IL-1 alpha and IL-6, but not against TNF alpha or IL-1 beta. There are significant methodological pitfalls that hamper detection of IgG autoantibodies against cytokines.

Animals↗
PubMed1981

[Studies on the light transmittance of coloured plastic bottles for liquid pharmaceutical preparations. Part 43: Contributions to problems concerning the use of plastic containers for liquid pharmaceutical preparations (author's transl)].

To assess the light transmittance of coloured plastic bottles, studies were made using the photographic paper method and a spectrophotometric technique. According to its sensitivity between 400 and 500 nm, the photographic paper gives information as to this wavelength range, directional radiation and scattered light being covered. In contrast to this, the spectrophotometric method yields discriminating information on the wavelength range between 200 and 800 nm. Apart from a minimum transmittance up to 500 nm, the coloured plastic bottles should have a high transmittance greater than 700 to ensure high transparency. Of the dyes tested, Pigment Orange and Chromeophthal Brown give the plastic bottles light-protecting properties 4 years' storage, both of these dyes show changes in the light-protecting properties by which the light transmittance of plastic bottles coloured with them is increased. When these dyes are used in adequate concentrations, this increase in light transmittance will remain within allowable limits, provided direct solar radiation be avoided.

Coloring Agents↗